# K061087: Genesis Otc Monitor

- Pathway: 510(k) (Traditional)
- Applicant: Honeywell Hommed, LLC
- Decided: Jun 9, 2006 after 52 days
- Product code: DRG (Transmitters And Receivers, Physiological Signal, Radiofrequency)
- Device class: 2
- Regulation: 21 CFR 870.2910
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K040799 (2004). 1 ancestor in all.
48 later devices descend from it; 3 cite it directly.
0 of 50 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K040799: Hommed Genesis Patient Monitor System with Options, Hommed, LLC (2004) Summary page 1.

## Most influential descendants
- K072698: Confidant 2.5 (2007), 34 descendants of its own
- K101242: Genesis DM Model: 6053000A1 (2010), 18 descendants of its own
- K083862: Medapps 2.0 Remote Patient Monitoring System (2009), 12 descendants of its own
- K112858: Genesis Touch System (2012), 11 descendants of its own
- K092635: Alcatel-Lucent Teleheath Manager (2009), 9 descendants of its own

## Indications for use
The Honeywell HomMed Genesis OTC Monitor is designed to retrospectively monitor vital signs. Vital signs include noninvasive blood pressure, pulse rate, and weight. Data from optional commercial stand-alone products extend Genesis OTC Monitor's measurement capabilities. Data from the Genesis OTC Monitor can be transmitted via a communication module to a central viewing station for display. The Genesis OTC Monitor is not intended for emergency use or real-time monitoring.

Source page: https://510kreport.com/device/K061087
Methodology: https://510kreport.com/methodology